Ruscetti is one of 13 early-career scientists recognized for groundbreaking, visionary research accelerating progress toward new cancer treatments and cures.
Conducting collaborative, cutting-edge research to unravel molecular, cellular and genetic mechanisms of disease and translate our discoveries into innovative therapeutic strategies
Research
Explore how our bold discoveries are redefining our understanding of how diseases start and can be treated.
Education
Find out how MCCB equips students and early-career researchers with the skills and knowledge to drive scientific discovery.
Support
Learn more about how you can support MCCB’s fundraising initiatives to advance research at UMass Chan.
MCCB Recognitions & Achievements
Grants, Honors & Awards
Getting Results…
Engineering a New Approach to Pancreatic Cancer Immunotherapy
Marcus Ruscetti, PhD, and Prabhani Atukorale, PhD, have received an NCI R01 grant to advance a multi-targeted nanoparticle-based immunotherapy designed to improve treatment of pancreatic cancer.